481 related articles for article (PubMed ID: 30367640)
1. Bacterial contamination of platelets for transfusion: strategies for prevention.
Levy JH; Neal MD; Herman JH
Crit Care; 2018 Oct; 22(1):271. PubMed ID: 30367640
[TBL] [Abstract][Full Text] [Related]
2. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
3. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
BioDrugs; 2003; 17(1):66-8. PubMed ID: 12534321
[TBL] [Abstract][Full Text] [Related]
4. Bacterial detection of platelets: current problems and possible resolutions.
Blajchman MA; Beckers EA; Dickmeiss E; Lin L; Moore G; Muylle L
Transfus Med Rev; 2005 Oct; 19(4):259-72. PubMed ID: 16214015
[TBL] [Abstract][Full Text] [Related]
5. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
Hillyer CD; Josephson CD; Blajchman MA; Vostal JG; Epstein JS; Goodman JL
Hematology Am Soc Hematol Educ Program; 2003; ():575-89. PubMed ID: 14633800
[TBL] [Abstract][Full Text] [Related]
6. Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction.
Fadeyi EA; Wagner SJ; Goldberg C; Lu T; Young P; Bringmann PW; Meier NM; Namen AM; Benjamin RJ; Palavecino E
Transfusion; 2021 Feb; 61(2):641-648. PubMed ID: 33616945
[TBL] [Abstract][Full Text] [Related]
7. Bacterial contamination of platelet components: potential solutions to prevent transfusion-related sepsis.
Corash L
Expert Rev Hematol; 2011 Oct; 4(5):509-25. PubMed ID: 21939419
[TBL] [Abstract][Full Text] [Related]
8. Improving the bacteriological safety of platelet transfusions.
Blajchman MA; Goldman M; Baeza F
Transfus Med Rev; 2004 Jan; 18(1):11-24. PubMed ID: 14689374
[TBL] [Abstract][Full Text] [Related]
9. Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems.
Benjamin RJ; Braschler T; Weingand T; Corash LM
Transfusion; 2017 Dec; 57(12):2946-2957. PubMed ID: 28840603
[TBL] [Abstract][Full Text] [Related]
10. Bacterial contamination and septic transfusion reaction rates associated with platelet components before and after introduction of primary culture: experience at a US Academic Medical Center 1991 through 2017.
Kundrapu S; Srivastava S; Good CE; Lazarus HM; Maitta RW; Jacobs MR
Transfusion; 2020 May; 60(5):974-985. PubMed ID: 32357261
[TBL] [Abstract][Full Text] [Related]
11. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.
Kaiser-Guignard J; Canellini G; Lion N; Abonnenc M; Osselaer JC; Tissot JD
Blood Rev; 2014 Nov; 28(6):235-41. PubMed ID: 25192602
[TBL] [Abstract][Full Text] [Related]
12. Transfusion of pathogen-reduced platelet components without leukoreduction.
Sim J; Tsoi WC; Lee CK; Leung R; Lam CCK; Koontz C; Liu AY; Huang N; Benjamin RJ; Vermeij HJ; Stassinopoulos A; Corash L; Lie AKW
Transfusion; 2019 Jun; 59(6):1953-1961. PubMed ID: 30919465
[TBL] [Abstract][Full Text] [Related]
13. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
14. Quality Improvement After Multiple Fatal Transfusion-Transmitted Bacterial Infections.
Corean J; Al-Tigar R; Pysher T; Blaylock R; Metcalf RA
Am J Clin Pathol; 2018 Mar; 149(4):293-299. PubMed ID: 29462235
[TBL] [Abstract][Full Text] [Related]
15. Pathogen inactivation/reduction technologies for platelet transfusion: Where do we stand?
Garraud O; Lozano M
Transfus Clin Biol; 2018 Sep; 25(3):165-171. PubMed ID: 30041847
[TBL] [Abstract][Full Text] [Related]
16. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance.
Hong H; Xiao W; Lazarus HM; Good CE; Maitta RW; Jacobs MR
Blood; 2016 Jan; 127(4):496-502. PubMed ID: 26598718
[TBL] [Abstract][Full Text] [Related]
17. [Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety].
Cazenave JP
Transfus Clin Biol; 2011 Apr; 18(2):53-61. PubMed ID: 21474358
[TBL] [Abstract][Full Text] [Related]
18. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets.
Jacobs MR; Good CE; Lazarus HM; Yomtovian RA
Clin Infect Dis; 2008 Apr; 46(8):1214-20. PubMed ID: 18444858
[TBL] [Abstract][Full Text] [Related]
19. Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review.
Cid J
Vox Sang; 2017 Oct; 112(7):607-613. PubMed ID: 28833219
[TBL] [Abstract][Full Text] [Related]
20. Implementation of amotosalen plus ultraviolet A-mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion-transmitted infections.
Richard P; Pouchol E; Sandid I; Aoustin L; Lefort C; Chartois AG; Baima A; Malard L; Bacquet C; Ferrera-Tourenc V; Gallian P; Laperche S; Bliem C; Morel P; Tiberghien P
Vox Sang; 2024 Mar; 119(3):212-218. PubMed ID: 38152857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
